Benjamin Haley, PhD, RemoteSenior Principal Scientist at Genentech, Inc
During his graduate studies at UMass Medical School, Ben unravelled several biochemical mechanisms that characterize the RNAi pathway. After receiving his PhD, he went to Michael Levine’s lab at UC Berkeley as an American Cancer Society Postdoctoral Fellow. There, he developed an enhanced Drosophila RNAi system for in vivo applications, further refined the in vivo specificity of RNAi, and identified novel aspects of small RNA biogenesis and mRNA structure/expression using a host of model organisms. Following his postdoc, Ben joined Genentech, Inc. where he currently serves as a point person for applied functional genetics. His lab is focused on developing technologies to better model human disease and therapeutic intervention using cell-based experiments.